関連する実験動画
Updated: Jun 24, 2026

07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
新しい抗マラリア化学型としての二重機能アクリドンの発見
Jane X Kelly1, Martin J Smilkstein, Reto Brun
1Portland Veterans Affairs Medical Centre, Portland, Oregon 97239, USA. kellyja@ohsu.edu
Nature
|April 10, 2009
まとめ
新しいアクリドン化合物であるT3.5は,多剤耐性マラリアとの闘いにおいて有望であることが示されています. それはヘムを標的とし,既存の抗マラリア薬を強化し,持続的なマラリア治療のための新しい戦略を提供します.
科学分野:
- 薬用化学 薬用化学について
- 寄生虫学とは,寄生虫学である.
- ドラッグ開発 ドラッグ開発
背景:
- 薬剤耐性は,マラリア治療における大きな課題です.
- モノセラピーと可変薬標的は,耐性を加速する.
- ハームの解毒は寄生虫の生存の重要な経路であり,脆弱な薬物標的である.
研究 の 目的:
- ハームを標的とした新しい抗マラリア化学型を開発し,薬剤耐性に対抗する.
- 鉛化合物T3.5.5の有効性および相乗効果を評価する.
主な方法:
- Plasmodium falciparumに対するアクリドン化学型T3.5の合成とインビトロ試験.
- 経口投与後のT3.5のインビボ有効性および安全性に関する研究.
- 既存の抗マラリア薬 (クロロクイン,アモディアクイン,キニン,ピペラクイン) との連携効果の評価.
主要な成果:
- T3.5は,薬剤に敏感で多剤耐性であるPlasmodium falciparumに対して高い効能を示した.
- この化合物は,クロロキンとアモディアキンに対する"ベラパミル様"の化学感受性を示した.
- T3.5は,キニンとピペラキンとの間で,in vitroとin vivoで,明確な相乗効果を示した.
結論:
- 新型アクリドンT3.5は,固有の抗マラリア効力を,耐性抑制機能と組み合わせています.
- この二重作用の分子は,抗マラリア薬の組み合わせを強化し,維持するための新しい戦略を表しています.
- T3.5は,マラリアにおける既存の薬剤耐性を克服するための有望なアプローチを提供します.
関連する概念動画
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
